Stock Chart (NASDAQ: IPCI)
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote (NASDAQ: IPCI)
Price: 1.96
Change: + 0.02
Day High: 1.99
Day Low: 1.93
Volume: 7,946
Delayed at least 20 minutes.
Provided by eSignal.

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company’s patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics has a pipeline of product candidates in various stages of development, including eight ANDAs as having been filed with the FDA, in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes, pain.

Recent Press Releases

May 10, 2017
Intellipharmaceutics Announces FDA Final Approval of Generic Seroquel XR®

Apr 18, 2017
Intellipharmaceutics Reports Director Election Results

View all releases »